T1	PROC 44 54	Valoración
#1	AnnotatorNotes T1	C1261322; Evaluation procedure; Health Care Activity
T2	CHEM 291 303	mitomicina-C
#2	AnnotatorNotes T2	C0002475; mitomycin; Organic Chemical · Antibiotic
T3	CHEM 94 104	mitomicina
#3	AnnotatorNotes T3	C0002475; mitomycin; Organic Chemical · Antibiotic
T4	PROC 106 115	instilada
#4	AnnotatorNotes T4	C0184959; Instillation (procedure); Health Care Activity
T5	DISO 146 151	tumor
#5	AnnotatorNotes T5	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T6	DISO 170 207	tumores vesicales no músculo invasivo
T7	ANAT 191 198	músculo
#6	AnnotatorNotes T7	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T8	CHEM 305 308	MMC
#7	AnnotatorNotes T8	C0002475; mitomycin; Organic Chemical · Antibiotic
T9	PROC 319 344	instilación electromotriz
T10	DISO 369 402	tumor vesical no músculo invasivo
T11	ANAT 386 393	músculo
#8	AnnotatorNotes T11	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T12	PROC 412 444	Estudio prospectivo aleatorizado
#9	AnnotatorNotes T12	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T13	PROC 468 478	Valoración
#10	AnnotatorNotes T13	C1261322; Evaluation procedure; Health Care Activity
T14	DISO 404 409	TVNMI
T15	CHEM 518 528	mitomicina
#11	AnnotatorNotes T15	C0002475; mitomycin; Organic Chemical · Antibiotic
T16	PROC 530 539	instilada
#12	AnnotatorNotes T16	C0184959; Instillation (procedure); Health Care Activity
T17	DISO 570 575	tumor
#13	AnnotatorNotes T17	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T18	DISO 594 631	tumores vesicales no músculo invasivo
T19	ANAT 615 622	músculo
#14	AnnotatorNotes T19	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T20	CHEM 719 731	mitomicina-C
#15	AnnotatorNotes T20	C0002475; mitomycin; Organic Chemical · Antibiotic
T21	CHEM 733 736	MMC
#16	AnnotatorNotes T21	C0002475; mitomycin; Organic Chemical · Antibiotic
T22	PROC 747 772	instilación electromotriz
T23	DISO 797 830	tumor vesical no músculo invasivo
T24	ANAT 814 821	músculo
#17	AnnotatorNotes T24	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T25	PROC 840 872	Estudio prospectivo aleatorizado
#18	AnnotatorNotes T25	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T26	DISO 917 949	carcinoma de células uroteliales
T27	PROC 774 778	EMDA
#19	AnnotatorNotes T27	[Electromotive drug administration]
T28	DISO 961 974	Tumor papilar
#20	AnnotatorNotes T28	C0476073; Papillary neoplasm; Neoplastic Process
T29	DISO 997 1013	Tumor recurrente
#21	AnnotatorNotes T29	C0521158; Recurrent tumor; Neoplastic Process
T30	ANAT 1073 1084	médula ósea
#22	AnnotatorNotes T30	C0005953; Bone Marrow; Tissue
T31	ANAT 1098 1114	glóbulos blancos
#23	AnnotatorNotes T31	C0023516; Leukocytes; Cell
T32	ANAT 1142 1151	plaquetas
#24	AnnotatorNotes T32	C0005821; Blood Platelets; Cell
T33	CHEM 1191 1201	creatinina
#25	AnnotatorNotes T33	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T34	ANAT 1202 1208	sérica
#26	AnnotatorNotes T34	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T35	ANAT 1237 1245	hepática
#27	AnnotatorNotes T35	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T36	PROC 1254 1283	gamma glutamil transpeptidasa
T37	PROC 1293 1317	alanina aminotransferasa
#28	AnnotatorNotes T37	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T38	PROC 1328 1345	bilirrubina total
#29	AnnotatorNotes T38	C0201913; Bilirubin, total measurement; Laboratory Procedure
T39	PROC 1361 1385	Consentimiento informado
#30	AnnotatorNotes T39	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T41	PROC 1544 1566	visitas de seguimiento
#31	AnnotatorNotes T41	C0589121; Follow-up visit; Health Care Activity
T42	DISO 1583 1599	tumor recurrente
#32	AnnotatorNotes T42	C0521158; Recurrent tumor; Neoplastic Process
T43	DISO 1630 1633	CIS
#33	AnnotatorNotes T43	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T44	ANAT 1657 1664	vesical
#34	AnnotatorNotes T44	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T45	PROC 1086 1114	recuento de glóbulos blancos
T46	DISO 1712 1725	tumor vesical
T47	DISO 1742 1745	CIS
#35	AnnotatorNotes T47	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T48	DISO 1764 1793	infección del tracto urinario
#36	AnnotatorNotes T48	C0042029; Urinary tract infection; Disease or Syndrome
T49	PROC 1798 1804	tratar
#37	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	DISO 1808 1827	Infección sistémica
#38	AnnotatorNotes T50	C0243026; Sepsis; Disease or Syndrome
T51	PROC 1837 1865	Tratamiento con radioterapia
T52	ANAT 2089 2097	cervical
#39	AnnotatorNotes T52	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T53	PROC 1868 1881	quimioterapia
#40	AnnotatorNotes T53	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T54	PROC 1884 1895	Tratamiento
#41	AnnotatorNotes T54	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T55	DISO 1925 1946	enfermedades malignas
T56	DISO 2026 2040	cáncer de piel
#42	AnnotatorNotes T56	C0007114; Malignant neoplasm of skin; Neoplastic Process | C0699893; Skin carcinoma; Neoplastic Process
T57	PROC 2045 2056	tratamiento
#43	AnnotatorNotes T57	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T58	DISO 2082 2097	cáncer cervical
#44	AnnotatorNotes T58	C0302592; Cervix carcinoma; Neoplastic Process
T59	PROC 61 75	administración
#45	AnnotatorNotes T59	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T60	ANAT 178 187	vesicales
#46	AnnotatorNotes T60	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T61	PROC 244 286	administración pre operatoria intravesical
T62	ANAT 375 382	vesical
#47	AnnotatorNotes T62	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T63	PROC 485 499	administración
#48	AnnotatorNotes T63	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T64	ANAT 602 611	vesicales
#49	AnnotatorNotes T64	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T65	PROC 672 714	administración pre operatoria intravesical
T66	ANAT 803 810	vesical
#50	AnnotatorNotes T66	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T67	ANAT 930 949	células uroteliales
T68	PROC 346 350	EMDA
#51	AnnotatorNotes T68	[Electromotive drug administration]
T69	DISO 832 837	TVNMI
T70	ANAT 967 974	papilar
#52	AnnotatorNotes T70	C3714556; Papilla; Body Part, Organ, or Organ Component
T71	ANAT 1173 1178	renal
#53	AnnotatorNotes T71	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T72	PROC 1191 1208	creatinina sérica
#54	AnnotatorNotes T72	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T73	CHEM 1328 1339	bilirrubina
#55	AnnotatorNotes T73	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T74	PROC 1130 1151	recuento de plaquetas
#56	AnnotatorNotes T74	C0032181; Platelet Count measurement; Laboratory Procedure
T75	ANAT 1718 1725	vesical
#57	AnnotatorNotes T75	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T76	ANAT 1778 1793	tracto urinario
#58	AnnotatorNotes T76	C0042027; Urinary tract; Body Part, Organ, or Organ Component | C1280341; Entire urinary tract; Body System
T77	CHEM 1900 1916	inmunosupresores
#59	AnnotatorNotes T77	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T78	ANAT 2036 2040	piel
#60	AnnotatorNotes T78	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T79	Date 12 16	2015
T80	LIVB 156 165	pacientes
#61	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T82	Route 274 286	intravesical
T83	LIVB 355 364	pacientes
#62	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T85	LIVB 580 589	pacientes
#63	AnnotatorNotes T85	C0030705; Patients; Patient or Disabled Group
T87	Route 702 714	intravesical
T88	LIVB 783 792	pacientes
#64	AnnotatorNotes T88	C0030705; Patients; Patient or Disabled Group
T90	LIVB 903 912	Pacientes
#65	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T92	LIVB 1048 1057	Pacientes
#66	AnnotatorNotes T92	C0030705; Patients; Patient or Disabled Group
T93	PHYS 1229 1245	función hepática
#67	AnnotatorNotes T93	C0232741; Liver function; Organ or Tissue Function
T95	LIVB 1437 1445	Paciente
#68	AnnotatorNotes T95	C0030705; Patients; Patient or Disabled Group
T96	LIVB 1466 1478	investigador
#69	AnnotatorNotes T96	C0035173; Research Personnel; Professional or Occupational Group
T97	PROC 1512 1525	cuestionarios
#70	AnnotatorNotes T97	C2960239; Assessment using health assessment questionnaire; Health Care Activity | C1882515; Questionnaire Administration; Health Care Activity
T98	LIVB 1569 1578	Pacientes
#71	AnnotatorNotes T98	C0030705; Patients; Patient or Disabled Group
T99	LIVB 1616 1625	Pacientes
#72	AnnotatorNotes T99	C0030705; Patients; Patient or Disabled Group
T101	Neg_cue 1794 1797	sin
T102	Duration 1955 1965	los 5 años
T103	Neg_cue 2004 2011	excepto
T104	PHYS 2113 2121	Embarazo
#73	AnnotatorNotes T104	C0032961; Pregnancy; Organism Function
T81	Time 76 90	pre operatoria
T84	Time 259 273	pre operatoria
T105	Time 500 514	pre operatoria
T86	Time 687 701	pre operatoria
T89	PHYS 1165 1178	función renal
#74	AnnotatorNotes T89	C0232804; Renal function; Organ or Tissue Function
T40	Neg_cue 1484 1494	incapaz de
T91	PHYS 1647 1664	Capacidad vesical
#75	AnnotatorNotes T91	C0232840; Bladder function; Organ or Tissue Function (?)
A1	Assertion T97 Negated
A2	Assertion T49 Negated
A3	Assertion T56 Negated
A4	Assertion T58 Negated
A5	Assertion T41 Negated
#76	AnnotatorNotes T81	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
#77	AnnotatorNotes T84	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
#78	AnnotatorNotes T105	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
#79	AnnotatorNotes T86	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
#80	AnnotatorNotes T82	C1522448; Intravesical Route of Drug Administration; Functional Concept
#81	AnnotatorNotes T87	C1522448; Intravesical Route of Drug Administration; Functional Concept
#82	AnnotatorNotes T26	C2145472; Urothelial Carcinoma; Neoplastic Process
#83	AnnotatorNotes T67	C1519839; Urothelial Cell; Cell
#84	AnnotatorNotes T45	C0023508; White Blood Cell Count procedure; Laboratory Procedure 
#85	AnnotatorNotes T36	C0017040; Gamma-glutamyl transferase; Amino Acid, Peptide, or Protein · Enzyme
#86	AnnotatorNotes T46	C0005695; Bladder Neoplasm; Neoplastic Process
#87	AnnotatorNotes T51	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
#88	AnnotatorNotes T55	C0006826; Malignant Neoplasms; Neoplastic Process
T94	Neg_cue 188 190	no
T100	Neg_cue 383 385	no
T106	Neg_cue 612 614	no
T107	Neg_cue 811 813	no
T108	Observation 191 207	músculo invasivo
A6	Assertion T108 Negated
#89	AnnotatorNotes T108	C4725840; Muscle Invasion; Finding
T109	Observation 386 402	músculo invasivo
A7	Assertion T109 Negated
#90	AnnotatorNotes T109	C4725840; Muscle Invasion; Finding
T110	Observation 615 631	músculo invasivo
A8	Assertion T110 Negated
#91	AnnotatorNotes T110	C4725840; Muscle Invasion; Finding
T111	Observation 814 830	músculo invasivo
A9	Assertion T111 Negated
#92	AnnotatorNotes T111	C4725840; Muscle Invasion; Finding
R1	Negation Arg1:T94 Arg2:T108	
R2	Negation Arg1:T100 Arg2:T109	
R3	Negation Arg1:T106 Arg2:T110	
R4	Negation Arg1:T107 Arg2:T111	
R5	Negation Arg1:T40 Arg2:T97	
R6	Negation Arg1:T40 Arg2:T41	
R7	Negation Arg1:T101 Arg2:T49	
R8	Negation Arg1:T103 Arg2:T56	
T112	Quantifier_or_Qualifier 2098 2108	localizado
A10	Assertion T112 Negated
R9	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T112	
R10	Negation Arg1:T103 Arg2:T58	
R11	Negation Arg1:T103 Arg2:T112	
T113	Result_or_Value 1677 1692	menos de 200 cc
R12	Location_of Arg1:T44 Arg2:T91	
R13	Has_Result_or_Value Arg1:T91 Arg2:T113	
T114	Observation 1665 1675	disminuida
#93	AnnotatorNotes T114	C0392756; Reduced; Finding (?)
R14	Has_Quantifier_or_Qualifier Arg1:T91 Arg2:T114	
R15	Overlap Arg1:T59 Arg2:T81	
R16	Used_for Arg1:T3 Arg2:T59	
T115	Quantifier_or_Qualifier 116 136	de manera localizada
#94	AnnotatorNotes T115	C0392752; Localized; Spatial Concept
R18	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T115	
R19	Experiences Arg1:T80 Arg2:T59	
R20	Experiences Arg1:T80 Arg2:T4	
R21	Experiences Arg1:T80 Arg2:T5	
R22	Experiences Arg1:T80 Arg2:T6	
R23	Location_of Arg1:T60 Arg2:T6	
R24	Location_of Arg1:T7 Arg2:T108	
#95	AnnotatorNotes T6	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#96	AnnotatorNotes T10	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#97	AnnotatorNotes T14	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#98	AnnotatorNotes T18	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#99	AnnotatorNotes T23	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#100	AnnotatorNotes T69	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
R27	Has_Route_or_Mode Arg1:T2 Arg2:T82	
R28	Has_Route_or_Mode Arg1:T8 Arg2:T82	
R29	Used_for Arg1:T2 Arg2:T61	
R30	Used_for Arg1:T8 Arg2:T61	
R34	Overlap Arg1:T61 Arg2:T68	
R17	Experiences Arg1:T83 Arg2:T61	
R31	Experiences Arg1:T83 Arg2:T9	
R32	Experiences Arg1:T83 Arg2:T68	
R33	Overlap Arg1:T61 Arg2:T9	
R36	Experiences Arg1:T83 Arg2:T10	
R37	Location_of Arg1:T62 Arg2:T10	
R38	Location_of Arg1:T11 Arg2:T109	
R40	Experiences Arg1:T83 Arg2:T14	
R41	Location_of Arg1:T62 Arg2:T14	
R26	Overlap Arg1:T2 Arg2:T84	
R44	Overlap Arg1:T8 Arg2:T84	
R45	Overlap Arg1:T63 Arg2:T16	
R46	Used_for Arg1:T15 Arg2:T63	
R47	Overlap Arg1:T15 Arg2:T105	
T116	Quantifier_or_Qualifier 540 560	de manera localizada
#101	AnnotatorNotes T116	C0392752; Localized; Spatial Concept
R48	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T116	
R49	Experiences Arg1:T85 Arg2:T63	
R50	Experiences Arg1:T85 Arg2:T16	
R51	Experiences Arg1:T85 Arg2:T17	
R52	Experiences Arg1:T85 Arg2:T18	
R53	Location_of Arg1:T64 Arg2:T18	
R54	Location_of Arg1:T19 Arg2:T110	
R56	Has_Route_or_Mode Arg1:T20 Arg2:T87	
R57	Has_Route_or_Mode Arg1:T21 Arg2:T87	
R58	Used_for Arg1:T20 Arg2:T65	
R59	Used_for Arg1:T21 Arg2:T65	
R60	Overlap Arg1:T20 Arg2:T86	
R61	Overlap Arg1:T21 Arg2:T86	
R62	Overlap Arg1:T65 Arg2:T22	
R63	Overlap Arg1:T65 Arg2:T27	
R64	Experiences Arg1:T88 Arg2:T65	
R65	Experiences Arg1:T88 Arg2:T22	
R66	Experiences Arg1:T88 Arg2:T27	
R67	Experiences Arg1:T88 Arg2:T23	
R68	Experiences Arg1:T88 Arg2:T69	
R69	Location_of Arg1:T66 Arg2:T23	
R71	Location_of Arg1:T24 Arg2:T111	
R73	Has_Quantifier_or_Qualifier Arg1:T69 Arg2:T111	
R75	Experiences Arg1:T90 Arg2:T26	
R76	Location_of Arg1:T67 Arg2:T26	
T117	Observation 950 952	Ta
#102	AnnotatorNotes T117	C3272501; Ta Stage Finding; Finding
R77	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T117	
T118	Observation 955 957	T1
#103	AnnotatorNotes T118	C0475372; Tumor stage T1; Finding
R78	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T118	
R79	Location_of Arg1:T70 Arg2:T28	
T119	Result_or_Value 1115 1128	≥4000 × 10³/L
R80	Has_Result_or_Value Arg1:T45 Arg2:T119	
R81	Experiences Arg1:T92 Arg2:T45	
R82	Experiences Arg1:T92 Arg2:T74	
T120	Result_or_Value 1152 1162	≥120×10³/L
R83	Has_Result_or_Value Arg1:T74 Arg2:T120	
T121	Quantifier_or_Qualifier 975 983	primario
#104	AnnotatorNotes T121	C0205225; Primary; Qualitative Concept
R84	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T121	
T122	Quantifier_or_Qualifier 984 994	alto grado
R85	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T122	
T123	Quantifier_or_Qualifier 1035 1045	bajo grado
R86	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T123	
T124	Quantifier_or_Qualifier 1014 1019	único
#105	AnnotatorNotes T124	C1710548; Unique; Qualitative Concept
R87	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T124	
T125	Quantifier_or_Qualifier 1022 1031	múltiples
#106	AnnotatorNotes T125	C0439064; Numerous; Quantitative Concept
R88	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T125	
T126	Observation 1062 1084	reserva de médula ósea
R89	Experiences Arg1:T92 Arg2:T126	
R90	Location_of Arg1:T30 Arg2:T126	
R91	Location_of Arg1:T71 Arg2:T89	
R93	Location_of Arg1:T34 Arg2:T72	
T127	Result_or_Value 1209 1225	≤123,76 µmol / L
R94	Has_Result_or_Value Arg1:T72 Arg2:T127	
R95	Location_of Arg1:T35 Arg2:T93	
T128	Result_or_Value 1284 1291	≤51 U/L
R97	Has_Result_or_Value Arg1:T36 Arg2:T128	
T129	Result_or_Value 1318 1325	≤50 U/L
R98	Has_Result_or_Value Arg1:T37 Arg2:T129	
T130	Result_or_Value 1346 1356	≤22 µmol/L
R101	Has_Result_or_Value Arg1:T38 Arg2:T130	
T131	Observation 1229 1252	función hepática normal
#107	AnnotatorNotes T131	C1848676; Normal liver function; Finding
R103	Location_of Arg1:T35 Arg2:T131	
R107	Experiences Arg1:T92 Arg2:T89	
R108	Experiences Arg1:T92 Arg2:T72	
R109	Experiences Arg1:T92 Arg2:T131	
R110	Experiences Arg1:T92 Arg2:T93	
R111	Experiences Arg1:T92 Arg2:T36	
R112	Experiences Arg1:T92 Arg2:T37	
R113	Experiences Arg1:T92 Arg2:T38	
T132	Observation 1165 1189	función renal conservada
#108	AnnotatorNotes T132	C0232805; Normal renal function; Finding (?)
R114	Location_of Arg1:T71 Arg2:T132	
R116	Experiences Arg1:T92 Arg2:T132	
R120	Experiences Arg1:T95 Arg2:T97	
R121	Experiences Arg1:T98 Arg2:T42	
T133	Quantifier_or_Qualifier 1603 1613	alto grado
R122	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T133	
R123	Experiences Arg1:T99 Arg2:T43	
T134	Observation 1634 1644	recurrente
#109	AnnotatorNotes T134	C0679254; Disease recurrence; Finding
R124	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T134	
T135	Quantifier_or_Qualifier 1729 1739	alto grado
R125	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T135	
R126	Location_of Arg1:T75 Arg2:T46	
R127	Location_of Arg1:T76 Arg2:T48	
T136	Quantifier_or_Qualifier 1828 1833	grave
#110	AnnotatorNotes T136	C1547227; Severe - Severity of Illness Code; Intellectual Product
R128	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T136	
R129	Used_for Arg1:T77 Arg2:T54	
R130	Has_Duration_or_Interval Arg1:T55 Arg2:T102	
T137	CONC 1979 1988	inclusión
#111	AnnotatorNotes T137	C1512693; Inclusion; Qualitative Concept
R131	Before Arg1:T55 Arg2:T137	
R132	Location_of Arg1:T78 Arg2:T56	
T138	Quantifier_or_Qualifier 2057 2065	efectivo
#112	AnnotatorNotes T138	C1704419; Effective; Qualitative Concept
R133	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T138	
R134	Location_of Arg1:T52 Arg2:T58	
#113	AnnotatorNotes T112	C0392752; Localized; Spatial Concept
R135	Before Arg1:T56 Arg2:T137	
R136	Before Arg1:T58 Arg2:T137	
R35	Overlap Arg1:T59 Arg2:T4	
R39	Location_of Arg1:T66 Arg2:T69	
R55	Experiences Arg1:T95 Arg2:T41	
#114	AnnotatorNotes T122	C5547531; High histologic grade; Classification
#115	AnnotatorNotes T135	C5547531; High histologic grade; Classification
#116	AnnotatorNotes T133	C5547531; High histologic grade; Classification
#117	AnnotatorNotes T123	C1282907; Low Grade; Qualitative Concept
A11	Experiencer T80 Patient
A12	Experiencer T83 Patient
A13	Experiencer T85 Patient
A14	Experiencer T88 Patient
A15	Experiencer T90 Patient
A16	Experiencer T92 Patient
A17	Experiencer T96 Other
A18	Experiencer T95 Patient
A19	Experiencer T98 Patient
A20	Experiencer T99 Patient
